A Cross-Sectional Study on the Prevalence and Risk Factors of Erectile Dysfunction Among Young and Middle-Aged Male Patients with Diabetes Mellitus at a Tertiary Hospital in Manila

Edmond R. David, Elaine C. Cunanan, Erick S. Mendoza

Apr 2026 DOI 10.35460/2546-1621.2025-0223     Access   

Abstract

This study aims to determine the prevalence of erectile dysfunction (ED) and identify its associated risk factors among young and middle-aged Filipino male patients diagnosed with diabetes mellitus. This study utilized a cross-sectional design to investigate the prevalence and associated factors of ED among male patients with diabetes. A total of 423 participants were recruited from clinical settings using purposive sampling. Data were collected using structured interviews and medical records, including demographics, comorbidities and laboratory results. Among 423 male diabetic patients, 78% were found to have ED. Patients with ED were significantly older (median: 49.5 versus 42 years, p<0.001), had higher body mass index (BMI), longer diabetes duration and more comorbidities. Univariable logistic regression showed that age (OR: 1.06, p<0.001), diabetes duration (OR: 1.11, p<0.001), hypertension (OR: 1.62, p = 0.042), dyslipidemia (OR: 1.75, p = 0.022), elevated HbA1c (>9.0%; OR: 3.43, p = 0.034) and serum creatinine (OR: 1.01, p = 0.008) were significantly associated with ED. However, none remained significant in the multivariable model. Male Filipino patients with diabetes have a significant burden of ED. Results of the univariable models show that age, duration of diabetes, hypertension, dyslipidemia, HbA1c and serum creatinine are significant individual predictors of ED.

Key Words: Diabetes Mellitus, Erectile Dysfunction, Philippines

  1. Weldesenbet AB, Kebede SA, Tusa BS. Prevalence of erectile dysfunction and its associated factors among patients with diabetes in Ethiopia: a systematic review and meta-analysis. J Int Med Res [Internet]. 2021;49(2):300060521993318. Available from: http://dx.doi.org/10.1177/0300060521993318 
  2. Maiorino MI, Bellastella G, Esposito K. Diabetes and sexual dysfunction: current perspectives. Diabetes Metab Syndr Obes [Internet]. 2014;7:95–105. Available from: http://dx.doi.org/10.2147/DMSO.S36455 
  3. Defeudis G, Mazzilli R, Tenuta M, Rossini G, Zamponi V, Olana S, et al. Erectile dysfunction and diabetes: A melting pot of circumstances and treatments. Diabetes Metab Res Rev [Internet]. 2022;38(2):e3494. Available from: http://dx.doi.org/10.1002/dmrr.3494 
  4. Goyal A, Singh P, Ahuja A. Prevalence and severity of erectile dysfunction as assessed by IIEF-5 in north Indian type 2 diabetic males and its correlation with variables. J Clin Diagn Res [Internet]. 2013;7(12):2936–8. Available from: http://dx.doi.org/10.7860/JCDR/2013/7718.3777 
  5. Piores O, Jimeno C, Trajano-Acampado L. Erectile dysfunction among diabetic men at UP-PGH Outpatient Department: Prevalence and risk factors. Philippine Journal of Internal Medicine [Internet]. 2004 June 30 [cited 2025 June 28];42(4). Available from: https://www.herdin.ph/index.php?view=research&cid=36604 
  6. De Guzman S. Prevalence and predictors of erectile dysfunction among Filipino men on social media: A cross-sectional study [Internet]. Research Square. 2023. Available from: http://dx.doi.org/10.21203/rs.3.rs-3315876/v2 
  7. Zeleke M, Hailu D, Daka D. Erectile dysfunction and associated factors among diabetic patients at, Hawassa, Southern, Ethiopia. BMC Endocr Disord [Internet]. 2021;21(1):139. Available from: http://dx.doi.org/10.1186/s12902-021-00807-5 
  8. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology [Internet]. 1997;49(6):822–30. Available from: http://dx.doi.org/10.1016/s0090-4295(97)00238-0 
  9. Kouidrat Y, Pizzol D, Cosco T, Thompson T, Carnaghi M, Bertoldo A, et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med [Internet]. 2017;34(9):1185–92. Available from: http://dx.doi.org/10.1111/dme.13403 
  10. Parmar RS, Verma S, Neelkamal, Pathak VK, Bhadoria AS. Prevalence of erectile dysfunction in type 2 diabetes mellitus (T2DM) and its predictors among diabetic men. J Family Med Prim Care [Internet]. 2022;11(7):3875–9. Available from: http://dx.doi.org/10.4103/jfmpc.jfmpc_1130_21 
  11. Bates JN, Pastuszak AW, Khera M. Effect of body weight on sexual function in men and women. Curr Sex Health Rep. 2019;11:52–9. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31576197 
  12. Dilixiati D, Waili A, Tuerxunmaimaiti A, Tao L, Zebibula A, Rexiati M. Risk factors for erectile dysfunction in diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol (Lausanne) [Internet]. 2024;15:1368079. Available from: http://dx.doi.org/10.3389/fendo.2024.1368079 
  13. Kitaw TA, Abate BB, Tilahun BD, Yilak G, Rede MB, Getie A, et al. The global burden of erectile dysfunction and its associated risk factors in diabetic patients: an umbrella reviews. BMC Public Health [Internet]. 2024;24(1):2816. Available from: http://dx.doi.org/10.1186/s12889-024-20300-7 
  14. Parvthaneni A, Kodithyala PK, Karangula S. Prevalence and risk factors of erectile dysfunction among patients with type II diabetes mellitus at a tertiary care centre in Hyderabad. MRIMS Journal of Health Sciences [Internet]. 2023;11(1):65–9. Available from: http://dx.doi.org/10.4103/mjhs.mjhs_33_22 
  15. Muniandy V, Ng YY, Yaacob LH, Ahmad I, Draman N, Muhamad R, et al. Prevalence and determinants of erectile dysfunction among male type 2 diabetes mellitus patients with chronic kidney disease: a cross-sectional study. Transl Androl Urol [Internet]. 2025;14(3):578–88. Available from: http://dx.doi.org/10.21037/tau-2024-751 
  16. Hosmer DW, Lemeshow S, Sturdivant RX. Applied Logistic Regression. 3rd ed. Hoboken. NJ: John Wiley & Sons; 2013.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.